Definitive Contract HHSD200201792732C
Award Date 12/23/16
Potential Completion Date 2/28/18
Potential Value $12M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $102,189,000.00, was issued by the Centers for Disease Control and Prevention (CDC) to Glaxosmithkline, LLC, a pharmaceutical company, to provide adult influenza vaccines. The contract is a definitive, firm fixed-price contract without any set-aside designation. Glaxosmithkline has provided a range of pharmaceutical goods and services to various U.S. government agencies, including vaccines, antiviral medications, and COVID-19 treatments. The company also...
- This is a federal contract award to GlaxoSmithKline, LLC, a pharmaceutical company, by the Centers for Disease Control and Prevention (CDC) for the provision of influenza vaccines. The contract, valued at $9,888,000.00, is a definitive contract with a firm fixed price. The award was made on December 18, 2015, and the ultimate completion date is February 28, 2017. The contract has no set-aside designation, and the place of performance is in Research Triangle Park, North Carolina....
- This is a $69,857,670.45 firm fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Glaxosmithkline, LLC, doing business as Glaxosmithkline, for 2016 pandemic influenza preparedness efforts. The contract has a completion date of February 28, 2017 and was awarded on December 18, 2015. There was no set-aside designation used. Glaxosmithkline is a pharmaceutical company that provides vaccines, antiviral medications, and other products to various federal agencies,...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $62,089,503.55 firm fixed price contract to Glaxosmithkline, LLC to provide vaccines for adults. The contract, which has no set-aside designation, runs from July 1, 2015 to June 30, 2016 and is for the company's pharmaceutical products and vaccine services. Glaxosmithkline, a foreign-owned for-profit organization, has provided a range of vaccines and antiviral medications to various federal agencies through both contracts and...
- This is a federal contract award by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to GlaxoSmithKline, LLC, a pharmaceutical company, for the delivery of influenza vaccines. The contract is a Delivery Order issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with a Firm Fixed Price pricing type and a potential value of $1,319,230.00. There was no set-aside designation used for this award. GlaxoSmithKline has provided a...
- This federal contract award was made by the Centers for Disease Control and Prevention (CDC) to GlaxoSmithKline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The contract has a total ceiling value of $213,831.06 and was awarded on a firm fixed price basis with no set-aside designation. It is a delivery order under GlaxoSmithKline's existing General Services Administration Federal Supply Schedule...
- This is a $50,556,695.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The contract, titled "2016 VFA - GSK", is for a firm fixed price and has an ultimate completion date of June 30, 2017. It is not a set-aside contract. Glaxosmithkline has provided a range of pharmaceutical goods and...
- This is a $2,603,484.86 firm fixed price purchase order awarded by the U.S. Department of Health and Human Services to Glaxosmithkline, LLC for the supply of influenza vaccine for the 2015-2016 season. The contract did not have a set-aside designation. Glaxosmithkline, a pharmaceutical company that provides vaccines and other products to federal agencies, was the prime contractor on this award. The contract was performed at Glaxosmithkline's facilities in Research Triangle Park, North...
- This is a firm fixed price delivery order contract awarded by the Medical Supply Chain division of the Defense Department's Defense Logistics Agency (DLA) to GlaxoSmithKline, LLC for the provision of influenza virus vaccines. The contract has a ceiling value of $2,405,037.60 and a period of performance ending on September 30, 2016. The contract was not set aside for any specific business category. GlaxoSmithKline, a pharmaceutical company that provides vaccines and other products to U.S....
- The U.S. government agency, the Medical Supply Chain, has awarded a $1,400.00 firm fixed price delivery order contract to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of influenza virus vaccines. This contract has no set-aside designation and the performance will take place at Glaxosmithkline's facilities in Durham, North Carolina. Glaxosmithkline has also received several other federal contracts and grants to supply a range of pharmaceutical products and services, including...